GlassScriptPhysician profile
Peter Denoble
NPI 1285947689
$3,120.76
in general payments reported to CMS, 2019-2025
20 companies · $226 in 2025
The $226 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $86.78 · 2021: $1,594 · 2022: $325 · 2023: $362 · 2024: $258 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $846.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $1,383.54 | 2021-2024 | |
| Stryker Corporation | $369.78 | 2019-2025 | Variax, Conextions Tr Tendon Repair System-Implant Mechanism, Gamma |
| Globus Medical, INC. | $180.35 | 2023 | Proximal Humerus Strut, Ankle Fracture System, Distal Radius Plate |
| Trice Medical, INC. | $173.38 | 2021 | |
| Arteriocyte Medical Systems, INC. | $136.36 | 2019 | |
| Smith+Nephew, INC. | $132.48 | 2021-2025 | Stravix Pl |
| Zimmer Biomet Holdings, INC. | $131.47 | 2020-2025 | Tapestry, Quattro |
| Axogen | $106.03 | 2019-2025 | |
| Depuy Synthes Sales INC. | $76.23 | 2022-2023 | Healix Knotless Peek, Dynacord, N/A |
| Electronic Waveform Lab, INC. | $74.42 | 2024 | |
| Endo Pharmaceuticals INC. | $74.37 | 2020-2023 | Xiaflex |
| Pacira Pharmaceuticals Incorporated | $50.15 | 2022-2024 | Exparel, Iovera, Zilretta |
| Davol INC. | $45.47 | 2023 | Arista Ah Flexitip |
| Integra Lifesciences Corporation | $41.05 | 2020-2021 | |
| Nuvasive, INC. | $40.27 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linkbio Corp | $25.49 | 2025 | |
| Biocomposites INC | $24.47 | 2021 | |
| Avanos Medical | $23.61 | 2023 | Trivisc Sodium Hyaluronate |
| Bridgebio Pharma, INC. | $18.17 | 2025 | Attruby |
| Heron Therapeutics, INC. | $13.67 | 2025 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Denoble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.